PFTV-012 – Jeanne Barnett and LouLou Brenneman Talk About Medrise @ ePatCon12

Video

Shwen Gwee talks to Jeanne Barnett (Founder, Medrise and CysticFibrosis.com) and Lauren (LouLou) Brenneman (Content Develoment and Patient Opinion Leader, Medrise)@ ePatCon 2012.

[vimeo http://vimeo.com/51370924 w=595&h=336]

If the video doesn’t work, please use the following link: http://vimeo.com/pharmfresh/pftv-2012-epatcon-medrise

Advertisements

PFTV-011 – Laura Kolodjeski Talks About Being a Community Manager in Pharma @ ePatCon12

Video

Marc Monseau interviews Laura Kolodjeski (Community Manager, Sanofi US Diabetes) @ ePatCon 2012.

If the video doesn’t work, please use the following link: http://vimeo.com/pharmfresh/pftv-2012-epatcon-lkolodjeski

Topics:

  • What are the responsibilities of a community manager (in pharma)?
  • How do you connect with the diabetes communities and become a legitimate participant in the conversation?
  • How do you demonstrate the value of your engagement with the community back to the diabetes franchise and your organization overall?
  • Through the insights you gain from being part of the community, are you able to create new approaches/product/interactions to bring value to the community?
  • Diabetes seems to be a category where pharma and patients have been very aggresive/engaged online with each other — do you see this happening in other therapeutic areas?
  • So much of Sanofi’s success in engaging in the diabetes space seems to be associated with the culture and leadership of the organization — what can the rest of the industry do to help make this happen with our own organizations?

PFTV-010 – Mark Bard Gives an Update on the Digital Health Coalition @ ePatCon12

Video

Marc Monseau interviews Mark Bard (Co-Founder and Board of Directors, Digital Health Coalition) @ ePatCon 2012.

If the video doesn’t work, please use the following link: http://vimeo.com/pharmfresh/pftv-2012-epatcon-markbard

Topics:

  • What’s the status of the Digital Health Coalition at the moment?
  • How receptive has the FDA been to some of the overtures that you’ve brought to them about how the industry should be behaving in the digital space?
  • What theories are you exploring around disclosures (via social media platforms)?
  • The financial industry has come up with several technological solutions to overcome  legal/regulatory concerns — is pharma industry really lagging in that respect?